Israelsson B, Berglund A, Ljungqvist U, Malmquist J
Scand J Clin Lab Invest. 1978 Jun;38(4):289-93. doi: 10.3109/00365517809108426.
The production of adenosine 3',5'-monophosphate (cyclic AMP) in a membrane preparation from human liver homogenate has been studied. Cyclic AMP production was enhanced by glucagon, guanylyl 5'-imidodiphosphate (GMP-PNP), or fluoride, or combinations of these. Adenosine, adenosine monophosphate (AMP) and adenosine diphosphate (ADP) at a concentration of 10(-3) mol/l antagonized the effects of all stimulants. These data suggest that inhibitory effects are exercised at the catalytic moiety of the adenylate cyclase system, or at the transducer function between hormone receptor and catalytic unit. In contrast, adenosine at a concentration of 10(-5) mol/l antagonized glucagon- but not fluoride-stimulated adenylate cyclase activity.
对人肝匀浆膜制剂中3',5'-环磷酸腺苷(环磷腺苷)的生成进行了研究。胰高血糖素、5'-亚氨二磷酸鸟苷(GMP-PNP)、氟化物或这些物质的组合可增强环磷腺苷的生成。浓度为10⁻³mol/L的腺苷、一磷酸腺苷(AMP)和二磷酸腺苷(ADP)可拮抗所有刺激物的作用。这些数据表明,抑制作用发生在腺苷酸环化酶系统的催化部分,或激素受体与催化单元之间的转导功能上。相比之下,浓度为10⁻⁵mol/L的腺苷可拮抗胰高血糖素刺激的腺苷酸环化酶活性,但不能拮抗氟化物刺激的腺苷酸环化酶活性。